|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
|
The
|
Large accelerated filer ☐
|
|
|
Accelerated filer ☐
|
Smaller reporting company
|
|
Emerging growth company
|
Item 1. |
Condensed Consolidated Financial Statements
|
September 30, | December 31, | |||||||
2024
|
2023
|
|||||||
(Unaudited) | ||||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Accounts receivable-trade, net of allowance for credit losses of $
|
|
|
||||||
Inventory
|
|
|
||||||
Income tax receivable
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
Property and equipment, at cost
|
|
|
||||||
Less accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
Property and equipment, net
|
|
|
||||||
Operating lease assets
|
|
|
||||||
Financing lease assets
|
|
|
||||||
Deferred income taxes
|
|
|
||||||
Other assets
|
|
|
||||||
TOTAL ASSETS
|
$
|
|
$
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Accounts payable-trade
|
$
|
|
$
|
|
||||
Accrued expenses and other liabilities
|
|
|
||||||
Income taxes payable |
||||||||
Current portion of operating lease liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Deferred income taxes | ||||||||
Uncertain tax positions
|
|
|
||||||
Other non-current liabilities
|
|
|
||||||
Operating lease liabilities, non-current
|
|
|
||||||
Finance lease liabilities, non-current
|
|
|
||||||
COMMITMENTS AND CONTINGENCIES (Note 6)
|
||||||||
STOCKHOLDERS’ EQUITY:
|
||||||||
Common stock, $
|
|
|
||||||
Paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Treasury stock at cost (
|
(
|
)
|
(
|
)
|
||||
Accumulated other comprehensive loss, net of tax
|
(
|
)
|
(
|
)
|
||||
Total stockholders’ equity
|
|
|
||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
|
$
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30, | |||||||||||||||
2024
|
2023
|
2024 |
2023 |
|||||||||||||
Net sales
|
$
|
|
$
|
|
$ | $ | ||||||||||
Cost of sales
|
|
|
||||||||||||||
Gross profit
|
|
|
||||||||||||||
Operating expenses
|
|
|
||||||||||||||
Income (loss) from operations
|
(
|
)
|
|
|||||||||||||
Other income (expense):
|
||||||||||||||||
Interest income
|
|
|
||||||||||||||
Other, net
|
(
|
)
|
(
|
)
|
( |
) | ( |
) | ||||||||
Total other income (expense)
|
|
(
|
)
|
( |
) | |||||||||||
Income (loss) before income taxes
|
(
|
)
|
|
|||||||||||||
Income tax provision (benefit)
|
(
|
)
|
|
|||||||||||||
Net income (loss)
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
Foreign currency translation adjustments, net of tax
|
|
(
|
)
|
( |
) | |||||||||||
Comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
Net income (loss) per common share:
|
||||||||||||||||
Basic
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
Diluted
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
Weighted average number of shares outstanding:
|
||||||||||||||||
Basic
|
|
|
||||||||||||||
Diluted
|
|
|
For the Nine Months Ended September 30,
|
||||||||
2024
|
2023
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
|
|
||||||
Operating lease asset amortization
|
|
|
||||||
Stock-based compensation
|
|
|
||||||
Deferred income taxes
|
( |
) | ||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable-trade
|
(
|
)
|
|
|||||
Inventory
|
(
|
)
|
(
|
)
|
||||
Prepaid expenses
|
(
|
)
|
|
|||||
Other current assets
|
|
|
||||||
Accounts payable-trade
|
(
|
)
|
(
|
)
|
||||
Accrued expenses and other liabilities
|
(
|
)
|
(
|
)
|
||||
Income taxes, net
|
(
|
)
|
|
|||||
Other assets
|
(
|
)
|
(
|
)
|
||||
Operating lease liabilities
|
(
|
)
|
(
|
)
|
||||
Total adjustments
|
(
|
)
|
(
|
)
|
||||
Net cash provided by operating activities
|
|
|
||||||
Cash flows from investing activities:
|
||||||||
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Payment of finance lease obligations
|
(
|
)
|
(
|
)
|
||||
Repurchase of common stock
|
( |
) | ||||||
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
||||
Effect of exchange rate changes on cash and cash equivalents
|
|
(
|
)
|
|||||
Net increase (decrease) in cash and cash equivalents
|
(
|
)
|
|
|||||
Cash and cash equivalents, beginning of period
|
|
|
||||||
Cash and cash equivalents, end of period
|
$
|
|
$
|
|
Number of
Shares
Common Stock
Outstanding
|
Par Value
|
Paid-in Capital
|
Treasury
Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Total
|
||||||||||||||||||||||
Balance, December 31, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Stock-based compensation expense
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Vesting of restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Repurchase of common stock | ||||||||||||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Foreign currency translation
adjustments, net of tax
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance, March 31, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Stock-based compensation expense
|
- | |||||||||||||||||||||||||||
Vesting of restricted stock units
|
||||||||||||||||||||||||||||
Repurchase of common stock
|
||||||||||||||||||||||||||||
Net income
|
- | |||||||||||||||||||||||||||
Foreign currency translation
adjustments, net of tax
|
- | |||||||||||||||||||||||||||
Balance, June 30, 2024
|
( |
) | ( |
) | ||||||||||||||||||||||||
Stock-based compensation expense | - | |||||||||||||||||||||||||||
Vesting of restricted stock units
|
||||||||||||||||||||||||||||
Repurchase of common stock
|
( |
) | ||||||||||||||||||||||||||
Net income (loss)
|
- | ( |
) | ( |
) | |||||||||||||||||||||||
Foreign currency translation
adjustments, net of tax
|
- | |||||||||||||||||||||||||||
Balance,September 30, 2024
|
( |
) | ( |
) | ||||||||||||||||||||||||
Balance, December 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
|
||||||||||||||
Stock-based compensation expense
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Vesting of restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Foreign currency translation
adjustments, net of tax
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Balance, March 31, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Stock-based compensation expense
|
- | |||||||||||||||||||||||||||
Vesting of restricted stock units
|
||||||||||||||||||||||||||||
Net income
|
- | |||||||||||||||||||||||||||
Foreign currency translation
adjustments, net of tax
|
- | ( |
) | ( |
) | |||||||||||||||||||||||
Balance, June 30, 2023
|
( |
) | ( |
) | ||||||||||||||||||||||||
Stock-based compensation expense
|
- | |||||||||||||||||||||||||||
Vesting of restricted stock units
|
||||||||||||||||||||||||||||
Repurchase of common stock | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Net income
|
- | |||||||||||||||||||||||||||
Foreign currency translation
adjustments, net of tax
|
- | ( |
) | ( |
) | |||||||||||||||||||||||
Balance, September 30, 2023
|
( |
) | ( |
) |
Three Months Ended September 30,
|
Nine Months Ended September 30, | |||||||||||||||
(in thousands) |
2024
|
2023
|
2024 | 2023 | ||||||||||||
United States
|
$
|
|
$
|
|
$ | $ | ||||||||||
Canada
|
|
|
||||||||||||||
Other | ||||||||||||||||
Net sales
|
$
|
|
$
|
|
$ | $ |
(in thousands)
|
September 30, 2024
|
December 31, 2023
|
||||||
Inventory on-hand:
|
||||||||
Finished goods held-for-sale
|
$
|
|
$
|
|
||||
Raw materials and work in-process
|
|
|
||||||
Inventory-in-transit
|
|
|
||||||
TOTAL
|
$
|
|
$
|
|
|
● |
Level 1 – observable inputs that reflect quoted prices in active markets for identical assets or liabilities.
|
|
● |
Level 2 – significant observable inputs other than quoted prices in active markets for similar assets and liabilities, such as quoted prices for identical or similar assets or liabilities in markets that
are not active; or other inputs that are observable or can be corroborated by observable market data.
|
|
●
|
Level 3 – significant unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants.
|
The Tandy Leather Factory, Inc. 2023 Incentive Stock Plan (the “2023 Plan” and, together with the 2013 Plan, the “Plans”) was adopted by our Board of Directors in April 2023 and approved by our stockholders in June 2023. The 2023 Plan initially reserved up to
Shares
(in thousands)
|
Weighted
Average
Share Price
|
|||||||
Balance, January 1, 2024
|
|
$
|
|
|||||
Granted
|
|
|
||||||
Forfeited | ( |
) | ||||||
Vested
|
|
|
||||||
Balance, September 30, 2024
|
|
$
|
|
Unrecognized Expense
|
||||
2024
|
$
|
|
||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
2028 |
||||
$
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30, |
|||||||||||||||
(in thousands, except share data)
|
2024
|
2023
|
2024
|
2023
|
||||||||||||
Numerator: | ||||||||||||||||
Net income (loss)
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
Denominator:
|
||||||||||||||||
Basic weighted-average common shares outstanding
|
|
|
||||||||||||||
Dilutive effect of service-based restricted stock awards granted to Board of Directors under the Plan
|
||||||||||||||||
Dilutive effect of service-based restricted stock awards granted to employees under the Plan
|
||||||||||||||||
Diluted weighted-average common shares outstanding
|
|
|
||||||||||||||
Basic earnings (loss) per share
|
( |
) | ||||||||||||||
Diluted earnings (loss) per share
|
( |
) |
Three Months Ended September 30,
|
||||||||||||||||
(in thousands)
|
2024
|
2023
|
$
Change
|
%
Change
|
||||||||||||
Sales
|
$
|
17,351
|
$
|
17,542
|
$
|
(191
|
)
|
(1.1
|
)%
|
|||||||
Gross profit
|
10,022
|
10,938
|
(916
|
)
|
(8.4
|
)%
|
||||||||||
Gross margin percentage
|
57.8
|
%
|
62.4
|
%
|
(4.6
|
)%
|
||||||||||
Operating expenses
|
10,289
|
10,058
|
231
|
2.3
|
%
|
|||||||||||
Income (loss) from operations
|
$
|
(267
|
)
|
$
|
880
|
$
|
(1,147
|
)
|
(130.3
|
)%
|
Three Months Ended September 30,
|
||||||||
(in thousands)
|
2024
|
2023
|
||||||
Operating expenses
|
$
|
10,289
|
$
|
10,058
|
||||
Adjusted operating expenses
|
$
|
10,289
|
$
|
10,058
|
||||
Operating expenses % of sales
|
59.3
|
%
|
57.3
|
%
|
||||
Adjusted operating expenses % of sales
|
59.3
|
%
|
57.3
|
%
|
Nine Months Ended September 30,
|
||||||||||||||||
(in thousands)
|
2024
|
2023
|
$ Change
|
% Change
|
||||||||||||
Sales
|
$
|
53,913
|
$
|
55,384
|
$
|
(1,471
|
)
|
(2.7
|
)%
|
|||||||
Gross profit
|
30,960
|
33,677
|
(2,717
|
)
|
(8.1
|
)%
|
||||||||||
Gross margin percentage
|
57.4
|
%
|
60.8
|
%
|
(3.4
|
)%
|
||||||||||
Operating expenses
|
30,515
|
31,027
|
(512
|
)
|
(1.8
|
)%
|
||||||||||
Income from operations
|
$
|
445
|
$
|
2,650
|
$
|
(2,206
|
)
|
(83.3
|
)%
|
Nine Months Ended September 30,
|
||||||||
(in thousands)
|
2024
|
2023
|
||||||
Operating expenses
|
$
|
30,515
|
$
|
31,027
|
||||
Adjusted operating expenses
|
$
|
30,515
|
$
|
31,027
|
||||
Operating expenses % of sales
|
56.6
|
%
|
56.0
|
%
|
||||
Adjusted operating expenses % of sales
|
56.6
|
%
|
56.0
|
%
|
(amounts in thousands)
|
2024
|
2023
|
||||||
Net cash provided by operating activities
|
$
|
37
|
$
|
1,204
|
||||
Net cash used in investing activities
|
(2,315
|
)
|
(334
|
)
|
||||
Net cash used in financing activities
|
(1
|
)
|
(23
|
)
|
||||
Effect of exchange rate changes on cash and cash equivalents
|
175
|
(199
|
)
|
|||||
Net increase (decrease) in cash and cash equivalents
|
$
|
(2,104
|
)
|
$
|
648
|
Item 4. |
Controls and Procedures.
|
PART II. |
OTHER INFORMATION
|
Item 1. |
Legal Proceedings.
|
Item 1A. |
Risk Factors.
|
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds.
|
ISSUER PURCHASES OF EQUITY SECURITIES
|
||||||||||||||||
Period
|
(a) Total
number of
shares
purchased
|
(b) Average
price paid
per share
|
(c) Total number of shares
purchased as part of
publicly announced plans
or programs
|
(d) Maximum value of
shares that may yet be
purchased under the plans
or programs
|
||||||||||||
July 1 – July 31, 2024
|
—
|
—
|
—
|
$
|
4,997,000
|
|||||||||||
August 1 – August 31, 2024
|
—
|
—
|
—
|
$
|
4,997,000
|
|||||||||||
September 1 – September 30, 2024
|
-
|
$
|
4.22
|
32
|
$
|
4,997,000
|
||||||||||
Total
|
—
|
—
|
32
|
Exhibit
Number
|
Description
|
3.1
|
|
3.2
|
|
3.3
|
|
3.4
|
|
4.1
|
|
10.1
|
10.2
|
|
10.3
|
|
10.4
|
|
10.5
|
|
10.6
|
|
10.7
|
|
10.8
|
|
14.1
|
|
21.1
|
|
13a-14(a) or 15d-14(a) Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities
Exchange Act of 1934, as amended.
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2022.
|
|
*101.INS
|
XBRL Instance Document.
|
*101.SCH
|
XBRL Taxonomy Extension Schema Document.
|
*101.CAL
|
XBRL Taxonomy Extension Calculation Document.
|
*101.DEF
|
XBRL Taxonomy Extension Definition Document.
|
*101.LAB
|
XBRL Taxonomy Extension Labels Document.
|
*101.PRE
|
XBRL Taxonomy Extension Presentation Document.
|
TANDY LEATHER FACTORY, INC.
|
|
(Registrant)
|
|
Date: November 12, 2024
|
By: /s/ Janet Carr
|
Janet Carr
|
|
Chief Executive Officer
|
|
(principal executive officer and principal financial officer)
|